Brain (and spinal cord) tumours

• For Researchers

The road to curing the incurable

Dr Lucy Brooks talks glioblastoma microenvironments and her excitement around potential new treatments Dr Lucy Brooks talks glioblastoma microenvironments and her excitement around potential new treatments

30 October 2024

• Science & Technology
• Charity News

£3m for world-first trial to revolutionise brain cancer treatment

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

23 October 2024

• Charity News

We’re accelerating brain tumour research with £8m more for our Brain Tumour Centres of Excellence

Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments. Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments.

24 September 2024

• Science & Technology

SU2C gives £7.5m more to improve treatments for children’s and young people’s cancers

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

7 August 2024

• Health & Medicine

NHS rolling out first targeted brain tumour treatment for children and young people

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

13 June 2024

• Science & Technology

New scan technique gives children the right medulloblastoma diagnosis in minutes, not weeks

A study we helped fund means children can get the right medulloblastoma treatments faster and puts an end to the long waits for answers. A study we helped fund means children can get the right medulloblastoma treatments faster and puts an end to the long waits for answers.

10 June 2024

• Science & Technology
• Health & Medicine

2023 roundup: 5 of our most important cancer research stories of the year

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

18 December 2023

• Science & Technology

The ecDNA story – catching the mastermind behind cancer evolution

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

20 February 2023

• Science & Technology

Feeling the pull: Using magnetic drug targeting to improve chemotherapy in brain tumours

Researchers at the University of Sheffield have developed a new magnetic device we could use to make more chemotherapy drugs effective against brain tumours. Researchers at the University of Sheffield have developed a new magnetic device we could use to make more chemotherapy drugs effective against brain tumours.

16 February 2023

• Health & Medicine

Better together: improving brain tumour treatment

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

13 February 2023

• For Researchers

The power of partnership – the unique alliance taking on brain cancer

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

15 December 2022

• Science & Technology
• Health & Medicine

Changes to chromosomes impact how children's brain tumours respond to treatment

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

4 November 2022